Skip to main content
Log in

IV levetiracetam in the management of non-convulsive status epilepticus

  • Brief Communication
  • Published:
Neurocritical Care Aims and scope Submit manuscript

Abstract

Introduction

Status epilepticus (SE) is a medical emergency requiring prompt treatment to try to limit mortality and improve outcome. So far, newer antiepileptic drugs (AED) have not assumed a noticeable role in the treatment of SE. This may be in part due to the lack of IV forms for the newer AEDs. The IV form of Levetiracetam (IV-LEV) has recently become available and has a potential role in the treatment of SE.

Methods and results

We report two cases of non-convulsive SE that responded favorably to IV-LEV. The first patient is an 83-year-old male with a history of complex partial seizure disorder who presented with impaired consciousness. The second patient is an 82-year-old male with history of old left middle cerebral artery ischemic infarction, who presented with confusion. Both patients were found to have a non-convulsive status epilepticus on electroencephalography (EEG) and treated with IV-LEV. In both cases, electrographic SE stopped with marked clinical improvement. Both patients tolerated the medication well and no significant side effects occurred.

Conclusion

IV-LEV may have a potential role in the treatment of non-convulsive status epileptics.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Patel NC, Landan IR, Levin J, Szaflarski J, Wilner AN. The use of levetiracetam in refractory status epilepticus. Seizure 2006;15(3):137–41.

    Article  PubMed  Google Scholar 

  2. Rossetti AO, Bromfield EB. Levetiracetam in the treatment of status epilepticus in adults: a study of 13 episodes. Eur Neurol 2005;54(1):34–8.

    Article  PubMed  CAS  Google Scholar 

  3. Rupprecht S, Franke K, Fitzek S, Witte OW, Hagemann G. Levetiracetam as a treatment option in non-convulsive status epilepticus. Epilepsy Res 2006.

  4. Ramael S, Daoust A, Otoul C, et al. Levetiracetam intravenous infusion: a randomized, placebo-controlled safety and pharmacokinetic study. Epilepsia. 2006;47(7):1128–35.

    Article  PubMed  CAS  Google Scholar 

  5. Gillard M, Chatelain P, Fuks B. Binding characteristics of levetiracetam to synaptic vesicle protein 2A (SV2A) in human brain and in CHO cells expressing the human recombinant protein. Eur J Pharmacol 2006;536(1–2):102–8.

    Article  PubMed  CAS  Google Scholar 

  6. Loscher W, Honack D, Rundfeldt C. Antiepileptogenic effects of the novel anticonvulsant levetiracetam (ucb L059) in the kindling model of temporal lobe epilepsy. J Pharmacol Exp Ther 1998;284(2):474–9.

    PubMed  CAS  Google Scholar 

  7. Dedeurwaerdere S, Vonck K, De Herdt V, et al. Neuromodulation with levetiracetam and vagus nerve stimulation in experimental animal models of epilepsy. Acta Neurol Belg 2006;106(2):91–7.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mounzer Y. Kassab.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Farooq, M.U., Naravetla, B., Majid, A. et al. IV levetiracetam in the management of non-convulsive status epilepticus. Neurocrit Care 7, 36–39 (2007). https://doi.org/10.1007/s12028-007-0022-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12028-007-0022-z

Keywords

Navigation